Detalles de la búsqueda
1.
Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program.
BMC Cancer
; 19(1): 12, 2019 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30612558
2.
Incidence and nature of testicular toxicity findings in pharmaceutical development.
Birth Defects Res B Dev Reprod Toxicol
; 92(6): 511-25, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22162370
3.
Disease Characteristics and Completion of Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Radium-223 in an International Early Access Program.
Clin Genitourin Cancer
; 17(5): 348-355.e5, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31311763
4.
Daily vardenafil for 6 months has no detrimental effects on semen characteristics or reproductive hormones in men with normal baseline levels.
J Urol
; 179(3): 1060-5, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18206950
5.
Efficacy and tolerability of vardenafil in men with mild depression and erectile dysfunction: the depression-related improvement with vardenafil for erectile response study.
Am J Psychiatry
; 163(1): 79-87, 2006 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16390893
6.
Efficacy and Safety of Radium-223 Dichloride in Symptomatic Castration-resistant Prostate Cancer Patients With or Without Baseline Opioid Use From the Phase 3 ALSYMPCA Trial.
Eur Urol
; 70(5): 875-883, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27344296
7.
Safety and efficacy of vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomy.
J Urol
; 170(4 Pt 1): 1278-83, 2003 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-14501741
Resultados
1 -
7
de 7
1
Próxima >
>>